Table 2.

Clinical manifestations of spondyloarthritis at onset and during followup.

Systematic Review — 42 Papers
At Onset						During Followup

Women		Men		p	Clinical Manifestations	Women		Men		p
No. Papers	% (CI 95%)	No. Papers	% (CI 95%)	p	Clinical Manifestations	No. Papers	% (CI 95%)	No. Papers	% (CI 95%)	p
6	69.7 (48.6–90.7)	5	69.3 (45.2–93.5)	0.9	Back pain: lumbar/dorsal	8	82.9 (64.3–100)	5	78 (48.5–100)	0.6
2	19.8 (0–100)	2	14.4 (0–100)	0.4	Neck pain	9	31.3 (13–49.7)	7	24.6 (7.9–41.3)	0.7
4	37.2 (15.2–59.3)	3	33.1 (0–79.1)	0.9	Peripheral arthritis	11	45 (32.5–57.5)	8	34.7 (22.5–47)	0.2
3	5.9 (2.8–9.1)	2	4.1 (0–21.8)	0.2	Enthesitis	5	37.4 (0–79)	5	27.8 (0–59.6)	0.8
1	11.0	1	12.0	NC	Uveitis	10	25.1 (12.3–37.9)	7	16.3 (6.2–26.4)	0.3
Metaanalysis — 13 Papers (16 samples)
At Onset						During Followup
Women		Men		p	Clinical Manifestations	Women		Men		p
No. Papers	% (CI 95%)	No. Papers	% (CI 95%)	p	Clinical Manifestations	No. Papers	% (CI 95%)	No. Papers	% (CI 95%)	p
3	69.3 (8.2–100)	3	66.7 (5.6–100)	0.5	Back pain: lumbar/dorsal	3	59.0 (13.4–100)	3	65.0 (10.1–100)	0.8
2	19.8 (0.100)	2	14.4 (0–100)	0.4	Neck pain	3	27.8 (0–75.3)	3	21.6 (0–68.8)	0.5
2	44.2 (0–100)	2	41.5 (0.100)	0.9	Peripheral arthritis	5	34.4 (10.2–58.5)	5	32.1 (9.6–54.7)	0.9
1	6.5	1	2.7	NC	Enthesitis	4	43.8 (0–99.5)	4	30.8 (0–76.2)	0.5
1	11.0	1	12	NC	Uveitis	3	15.5 (0–39.8)	3	13.8 (0–33.6)	0.8